# A Tale of Two Infections: A Rare Synchronous Infection of Herpes Simplex Virus Oesophagitis and Clostridium difficile in an Immunocompetent Host

**Authors:** Sujata Lama, Aye Thinzar Moe, Amirat Akinloye, Kyaw Soe Tun, Jithin Karedath

PMC · DOI: 10.7759/cureus.94660 · 2025-10-15

## TL;DR

An elderly immunocompetent woman experienced rare simultaneous infections of HSV oesophagitis and C. difficile, highlighting the role of non-traditional risk factors.

## Contribution

The paper presents a rare case of synchronous HSV oesophagitis and C. difficile infection in an immunocompetent patient.

## Key findings

- A 95-year-old woman had concurrent HSV oesophagitis and C. difficile infection without typical risk factors.
- The patient showed marked improvement after dual antimicrobial therapy.
- Non-traditional risk factors like immunosenescence and PPI use may contribute to such infections.

## Abstract

Herpes simplex virus (HSV) is a common cause of infectious oesophagitis, predominantly affecting immunocompromised populations. Clostridium difficile (C. difficile), while prevalent in this population, is also a frequently encountered cause of nosocomial diarrhoea associated with antibiotic exposure, prolonged hospitalisation, or residence in long-term care facilities. A simultaneous HSV oesophagitis and C. difficile infection (CDI), despite the absence of the typical risk factors, is rare but possible, as illustrated by the following case.

A 95-year-old female patient presented with acute confusion, abdominal pain, diarrhoea, odynophagia, and dysphagia. The stool sample detected toxigenic C. difficile, and a course of fidaxomicin was completed. Oesophagogastroduodenoscopy (OGD) observed mucosal changes consistent with HSV oesophagitis, but treatment was initially withheld due to pending histopathology. She was readmitted due to the recurrence of her symptoms. HSV was confirmed, and the patient started on dual antimicrobial therapy with marked improvement and resolution.

This case study prompts us to consider non-traditional risk factors such as immunosenescence, frailty, proton pump inhibitors (PPIs), and nutritional deficiencies in addition to the lack of primary prevention measures.

## Linked entities

- **Chemicals:** fidaxomicin (PubChem CID 10034073)
- **Diseases:** Clostridium difficile infection (MONDO:0000705), diarrhoea (MONDO:0001673)
- **Species:** Herpes Simplexvirus (taxon 3344809)

## Full-text entities

- **Diseases:** diarrhoea (MESH:D003967), Infection (MESH:D007239), HSV oesophagitis (MESH:D006561), abdominal pain (MESH:D015746), confusion (MESH:D003221), dysphagia (MESH:D003680), infectious oesophagitis (MESH:D003141), C. difficile infection (MESH:D003015), nutritional deficiencies (MESH:D044342)
- **Chemicals:** fidaxomicin (MESH:D000077732)
- **Species:** Clostridioides difficile (species) [taxon 1496], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12618019/full.md

---
Source: https://tomesphere.com/paper/PMC12618019